Hudson Bay Capital Management
RVPH

Hudson Bay Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Hudson Bay Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40,500
Closed -$8.78M – 691
2020
Q3 		$8.78M Hold
40,500
– – 0.13% 131
2020
Q2 		$8.71M Hold
40,500
– – 0.15% 113
2020
Q1 		$8.52M Buy
40,500
+39,900
+6,650% +$8.37M 0.21% 86
2019
Q4 		$126K Buy
+600
New +$125K ﹤0.01% 375

Other funds holding RVPH

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Hudson Bay Capital Management's RVPH Position: Q4 2020 in Review

Hudson Bay Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 40,500 shares — an estimated $8.78M sold.

Hudson Bay Capital Management first reported a position in RVPH in Q4 2019 and held it in 4 quarters. The position peaked at $8.78M in Q3 2020. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

  • Hudson Bay Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 40,500 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $8.78M.
  • Hudson Bay Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2019 and held it in 4 quarters.
  • Hudson Bay Capital Management's REVIVA PHARMA HLDGS INC position peaked at $8.78M in Q3 2020.
  • 3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on Hudson Bay Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.